Accessibility settings

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/93547, first published .
3D scan of child's skeletal system and internal organs with IV drip

[177Lu]Lu-DOTATATE Molecular Radiotherapy During Induction Chemotherapy for First-Line Stage 4 High-Risk Neuroblastoma in South African Children: Protocol for a Phase 1 Randomized Controlled Trial (LuDO-SA Trial)

[177Lu]Lu-DOTATATE Molecular Radiotherapy During Induction Chemotherapy for First-Line Stage 4 High-Risk Neuroblastoma in South African Children: Protocol for a Phase 1 Randomized Controlled Trial (LuDO-SA Trial)

Jaques van Heerden   1, 2 * , MD, PhD ;   Mariana Kruger   1, 3 * , MD, PhD ;   Kershinee Reddy   4, 5 * , MD, MMed ;   Anel van Zyl   1 * , MD, PhD ;   James Warwick   6 * , MD, PhD ;   Celeste Burger   6 * , MD, MMed ;   Tumelo Moalosi   6 * , MSc ;   Christoffel van Reenen   6 * , MSc ;   Alan Davidson   7 * , MD, M Phil ;   Khanyisile Hlongwa   8 * , MD, MMed ;   Daniella Violante   8, 9 * , MSc ;   Nanette Bruwer   6 * , MSc ;   Gita Naidu   10 * , MD, PhD ;   Biance Rowe   10 * , MD, MMed ;   Lizette Louw   11 * , MD, MMed ;   Bronwin van Wyk   12 * , PhD ;   Mariza Vorster   13 * , MD, PhD ;   Thokozani Mkhize   13 * , MSc ;   Anita Brink   14 * , MD, PhD

1 Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Tygerberg Hospital, Stellenbosch University, Cape Town, Western Cape, South Africa

2 Department of Paediatric Haemato-Oncology, MIPRO laboratory, Antwerp University Hospital, University of Antwerp, Antwerp Province, Belgium

3 School of Psychology, University of KwaZulu-Natal, Pietermaritzburg, KwaZulu-Natal, South Africa

4 Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp Province, Belgium

5 Department of Paediatric Haemato-Oncology, Department of Paediatrics and Child Health, Inkosi Albert Luthuli Central Hospital, University of Kwa-Zulu Natal, Durban, KwaZulu-Natal, South Africa

6 Department of Nuclear Medicine, Faculty of Medicine and Health Sciences, Tygerberg Hospital, Stellenbosch University, Cape Town, Western Cape, South Africa

7 Division of Paediatric Haematology and Oncology, Red Cross War Memorial Children’s Hospital, Department of Paediatrics and Child Health, University of Cape Town, Cape Town, Western Cape, South Africa

8 Division of Nuclear Medicine, Red Cross War Memorial Children’s Hospital, Department of Paediatrics and Child Health, University of Cape Town, Cape Town, Western Cape, South Africa

9 Department of Nuclear Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, Western Cape, South Africa

10 Department of Paediatric Haemato-Oncology, Department of Paediatrics and Child Health, University of the Witwatersrand, Chris Hani Baragwanath Academic Hospital, Johannesburg, Gauteng, South Africa

11 Center of Molecular Imaging and Theranostics, Johannesburg, Gauteng, South Africa

12 Department of Medical Physics, Dr George Mukhari Academic Hospital, Sefako Makgatho University, Ga-Rankuwa, Gauteng, South Africa

13 Department of Nuclear Medicine, Inkosi Albert Luthuli Central Hospital, University of KwaZulu Natal, Durban, Kwa-Zulu Natal, South Africa

14 Nuclear Medicine and Diagnostic Imaging Section, Division of Human of Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria

*all authors contributed equally

Corresponding Author:

  • Jaques van Heerden, MD, PhD
  • Department of Paediatrics and Child Health
  • Faculty of Medicine and Health Sciences, Tygerberg Hospital, Stellenbosch University
  • Stellenbosch University, Tygerberg Campus, Francie van Zijl Drive
  • Cape Town, Western Cape 7505
  • South Africa
  • Phone: 27 219389506
  • Email: jaquesvanheerden@gmail.com